Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2
- 1 August 2007
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (15), 4191-4195
- https://doi.org/10.1016/j.bmcl.2007.05.041
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening ApplicationJournal of Medicinal Chemistry, 2006
- Inspecting the Structure-Activity Relationship of Protein Kinase CK2 Inhibitors Derived from Tetrabromo-BenzimidazoleCell Chemical Biology, 2005
- Features and potentials of ATP-site directed CK2 inhibitorsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2005
- Role for casein kinase 2 in the regulation of HIF‐1 activityInternational Journal of Cancer, 2005
- CK2 Inhibits Apoptosis and Changes Its Cellular Localization Following Ionizing RadiationCancer Research, 2005
- Protein kinase CK2 phosphorylates and upregulates Akt/PKBCell Death & Differentiation, 2005
- Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesisOncogene, 2002
- A Phosphatase Associated with Metastasis of Colorectal CancerScience, 2001
- A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit αOncogene, 2001
- p53 deficiency and misexpression of protein kinase CK2α collaborate in the development of thymic lymphomas in miceOncogene, 1998